Total Revenue and Sequential Context
Q1 2026 total revenue of $21.1M (down from $25.2M in Q4 2025, a sequential decline of ~$4.1M or ~16.3%) — management attributes most of the decline to two nonrecurring items (California divestiture removing ~$2.5M of quarterly revenue and the absence of a one‑time Florida loyalty accrual benefit recognized in Q4). Adjusted for those items, underlying revenue was approximately flat sequentially.
Gross Profit and Margin Improvement
Gross profit of $9.4M and gross margin of 44.6%, flat as reported vs. Q4 but improved when excluding the one‑time Florida loyalty benefit (management cites a 5.4% improvement on that adjusted basis). Company expects additional gross margin upside in 2026 as BHO production comes online and one‑time dilutive items (sold CA inventory below cost) do not recur.
Retail Performance and DAZED! Strength
SuperStore (including DAZED!) generated $9.3M in Q1 (marginally up vs. Q4). DAZED! revenue grew ~47% year‑over‑year, demonstrating outsize performance from the destination concept. Combined SuperStore + neighborhood network retail totaled $20.2M in Q1.
Neighborhood Network and Florida Revenue
Neighborhood store network produced $10.9M in Q1 with Florida representing ~$8.0M of that total. Management reports April sequential improvements across Florida, Illinois and Nevada and states Q2 retail performance has tracked to internal plan.
Cost Reductions and SG&A Progress
Sales & marketing expense was $1.2M (roughly flat vs. Q4 and down ~22% year‑over‑year). G&A decreased to $11.2M from $12.0M in Q4 (a sequential reduction of ~$0.8M) and is down nearly $3.0M year‑over‑year, reflecting portfolio exits and continued cost discipline.
Working Capital, Cash and CapEx
Cash and restricted cash improved modestly to $16.3M at quarter end (up from $15.6M at year‑end). Operating cash flow was essentially breakeven for the quarter. Q1 CapEx was modest at $0.7M and management expects minimal CapEx for the remainder of 2026.
Wholesale Recovery in Nevada
Wholesale revenue was $0.9M in Q1 (down from $2.0M in Q4 due to the CA exit), but Nevada wholesale grew ~41% sequentially in Q1 — the third consecutive quarter of sequential wholesale growth in Nevada following the 2025 wholesale team restructuring.
Regulatory Rescheduling — Material Positive
On April 22, medical marijuana was rescheduled from Schedule I to Schedule III. Florida operations (representing ~40% of Q1 revenue and operating under state medical license) are now outside the scope of 280E on a go‑forward basis, which materially improves federal tax treatment and is expected to benefit profitability and cash flow going forward.
BHO Lab and Product Mix Upside
Florida BHO concentrate facility completed final inspections and received partial approvals; revenue expected beginning in Q2. Management expects BHO to expand higher‑margin product mix and be a meaningful contributor to gross margin and comparable sales in Florida in the back half of 2026.
Market Structure Improvements from Hemp Regulation
Clark County ordinance (effective mid‑July) and federal hemp restrictions (effective Nov 12) are expected to reduce competitive imbalance from intoxicating hemp products and provide operational benefits to state‑licensed cannabis operators in the back half of 2026 and into 2027.